$0.508200
-0.02-3.93%
At Close: -
$0.500000
-0.0082-1.61%
After Hours: 5:24 PM EDT
15 minutes delayed
Evoke Pharma
EVOKNASDAQ
Evoke Pharma (NASDAQ:EVOK) Stock, Earnings Estimates, EPS, And Revenue
Evoke Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$3M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$6.1M
Analyze the earnings history of Evoke Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOK | Evoke Pharma | -$0.56 | -$0.06 | — | — | $1.13M | $2.98M | — | — | 08/08/2024 | Get Alert |
| EVOK | Evoke Pharma | -$0.67 | -$0.21 | -$0.17 | 19.05% | $810.41K | $2.14M | $1.74M | -18.93% | 05/14/2024 | Get Alert |
| EVOK | Evoke Pharma | -$0.54 | -$0.50 | -$0.59 | -18.00% | $796.00K | $1.63M | $1.68M | 2.82% | 03/14/2024 | Get Alert |
| EVOK | Evoke Pharma | -$0.60 | -$0.62 | -$0.51 | 17.74% | $832.10K | $1.26M | $1.56M | 24.05% | 11/09/2023 | Get Alert |
| EVOK | Evoke Pharma | -$0.71 | -$0.73 | -$0.56 | 23.29% | $461.80K | $1.10M | $1.13M | 2.82% | 08/10/2023 | Get Alert |
| EVOK | Evoke Pharma | -$0.80 | -$0.58 | -$0.67 | -15.52% | $418.38K | $1.00M | $810.41K | -18.96% | 05/15/2023 | Get Alert |
| EVOK | Evoke Pharma | -$0.60 | -$0.53 | -$0.54 | -1.89% | $360.57K | $890.00K | $796.00K | -10.56% | 03/21/2023 | Get Alert |
| EVOK | Evoke Pharma | -$0.72 | -$0.66 | -$0.60 | 9.09% | $930.45K | $570.00K | $832.10K | 45.98% | 11/09/2022 | Get Alert |
| EVOK | Evoke Pharma | -$0.84 | -$0.60 | -$0.71 | -18.33% | $236.63K | $580.00K | $461.80K | -20.38% | 08/10/2022 | Get Alert |
| EVOK | Evoke Pharma | -$0.96 | -$0.48 | -$0.84 | -75.00% | $90.42K | $530.00K | $418.38K | -21.06% | 05/10/2022 | Get Alert |
| EVOK | Evoke Pharma | -$1.08 | -$0.96 | -$0.72 | 25.00% | $23.02K | $510.00K | $360.57K | -29.30% | 03/08/2022 | Get Alert |
| EVOK | Evoke Pharma | -$0.96 | -$0.84 | -$0.72 | 14.29% | $0.00 | $380.00K | $930.45K | 144.85% | 11/10/2021 | Get Alert |
| EVOK | Evoke Pharma | -$3.36 | -$0.96 | -$0.84 | 12.50% | $0.00 | $150.00K | $236.63K | 57.76% | 08/12/2021 | Get Alert |
| EVOK | Evoke Pharma | -$0.84 | -$0.72 | -$0.96 | -33.33% | $0.00 | $830.00K | $90.42K | -89.11% | 05/12/2021 | Get Alert |
| EVOK | Evoke Pharma | -$0.72 | -$1.56 | -$1.08 | 30.77% | $0.00 | $840.00K | $23.02K | -97.26% | 03/11/2021 | Get Alert |
| EVOK | Evoke Pharma | -$0.84 | — | -$0.96 | — | $0.00 | — | $0.00 | — | 11/10/2020 | Get Alert |
| EVOK | Evoke Pharma | -$1.08 | — | -$3.36 | — | $0.00 | — | $0.00 | — | 08/06/2020 | Get Alert |
| EVOK | Evoke Pharma | -$1.32 | — | -$0.84 | — | $0.00 | — | $0.00 | — | 05/12/2020 | Get Alert |
| EVOK | Evoke Pharma | -$1.20 | — | -$0.72 | — | $0.00 | — | $0.00 | — | 03/12/2020 | Get Alert |
| EVOK | Evoke Pharma | -$1.08 | — | -$0.84 | — | $0.00 | — | $0.00 | — | 11/07/2019 | Get Alert |
| EVOK | Evoke Pharma | -$1.68 | — | -$1.08 | — | $0.00 | — | $0.00 | — | 08/08/2019 | Get Alert |
Evoke Pharma (EVOK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $-0.17 | $-0.21 | 19.1 % |
| Dec 2023 | 2024-03-14 | $-0.59 | $-0.50 | -18.0 % |
| Sep 2023 | 2023-11-09 | $-0.51 | $-0.62 | 17.7 % |
| Jun 2023 | 2023-08-10 | $-0.56 | $-0.73 | 23.3 % |
Evoke Pharma (EVOK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $1.74M | $2.14M | -18.9 % |
| Dec 2023 | 2024-03-14 | $1.68M | $1.63M | 2.82 % |
| Sep 2023 | 2023-11-09 | $1.56M | $1.26M | 24.1 % |
| Jun 2023 | 2023-08-10 | $1.13M | $1.10M | 2.82 % |
FAQ
When is Evoke Pharma (NASDAQ:EVOK) reporting earnings?
Evoke Pharma (EVOK) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Evoke Pharma (NASDAQ:EVOK)?
The Actual EPS was $-0.17, which beat the estimate of $-0.21.
What were Evoke Pharma’s (NASDAQ:EVOK) revenues?
The Actual Revenue was $1.7M, which missed the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.